HIGHLIGHTS
- who: Attribution and colleagues from the Clinica di Ematologia Azienda Ospedaliero, Universitaria delle Marche, Ancona, Italy have published the research: Current Main Topics in Myeloma, in the Journal: Cancers 2023, 15, 2203. of 14/02/2023
- what: In this review, the authors summarized the more relevant topics regarding the approach to patients with MM with a focus on the most recent clinical data.
- future: Although ASCT still plays a significant role in patients who are eligible in the near future the unprecedented responses seen with quadruplet combinations including mAbs could modify this paradigm . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.